Skip to main content
search here
username password
Macmillan and Cancerbackup merged in 2008. Together we provide free, high quality information for people affected by cancer through our publications, website and phone service. Find out more| .
How we produce our information|
This information is about the use of aldesleukin as a treatment for people with cancer. It is mainly used to treat people with a type of kidney cancer known as renal cell carcinoma, but is sometimes used to treat other types of cancer.
Aldesleukin is a protein produced naturally in the body in very small amounts. It is produced by a type of white blood cell called a T-lymphocyte. It works as part of the body’s defence mechanism (immune system) in fighting illness.
Aldesleukin can be made commercially as a drug and is used as a treatment for cancer. It can be used to treat a few different types of cancer. These include some kidney tumours and melanoma. It can be given on its own or in combination with other treatments.
Aldesleukin used to be known as interleukin-2 or IL2.
Aldesleukin is a colourless fluid.
Aldesleukin is usually given as an injection under the skin (subcutaneously).
The amount of aldesleukin that occurs naturally in the body is very small, and so aldesleukin treatment greatly increases the amount in the body.
The length of the course of treatment, how often the injections are given and the dosage will vary according to your general health and the type of cancer.
Most people have aldesleukin as outpatients.
Aldesleukin is given to stimulate the body’s immune system to fight some types of cancer. The exact way in which it works is still not fully understood. However, it can stimulate white cells to recognise and destroy some cancer cells.
Each person’s reaction to any drug is different. Some people have very few side effects while others may experience more. The side effects described below will not affect everyone taking aldesleukin. We have outlined the most common side effects.
However, we have not included those that are very rare, and therefore unlikely to affect you. If you notice any effects that you think may be due to the drugs, but which are not listed here, please let your nurse or doctor know.
The side effects of aldesleukin usually disappear once the treatment has finished and may include any of those listed below:
Some patients having aldesleukin treatment have to stay in hospital for close monitoring. This may be necessary if treatment is given at higher doses, when side effects may be more severe.
Some patients give themselves aldesleukin injections at home. If this is the case, you must keep your aldesleukin in the refrigerator.
This information has been compiled using information from a number of reliable sources including:
British National Formulary. 58th edition. 2009. British Medical Association and Royal Pharmaceutical Society of Great Britain.
For further references, please see the general bibliography| .
Posted by Dianne J
Posted by lesley22
Posted by bob jk
If you have any questions about cancer, need support or just want someone to talk to, ask Macmillan.
Browser does not support script.